Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell–immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype

Archive ouverte

Cavazzana-Calvo, Marina | Carlier, Frédérique | Le Deist, Françoise | Morillon, Estelle | Taupin, Pierre | Gautier, David | Radford-Weiss, Isabelle | Caillat-Zucman, Sophie | Neven, Bénédicte | Blanche, Stephane | Cheynier, Rémi | Fischer, Alain | Hacein-Bey-Abina, Salima

Edité par CCSD ; American Society of Hematology -

International audience. Abstract We studied T-cell reconstitution in 31 primary T-cell–immunodeficient patients who had undergone hematopoietic stem-cell transplantation (HSCT) over 10 years previously. In 19 patients, there was no evidence of myeloid chimerism because little or no myeloablation had been performed. Given this context, we sought factors associated with good long-term T-cell reconstitution. We found that all patients having undergone full myeloablation had donor myeloid cells and persistent thymopoiesis, as evidenced by the presence of naive T cells carrying T-cell receptor excision circles (TRECs). In 9 patients with host myeloid chimerism, sustained thymic output was also observed and appeared to be associated with γc deficiency. It is therefore possible that the complete absence of thymic progenitors characterizing this condition created a more favorable environment for thymic seeding by a population of early progenitor cells with the potential for self-renewal, thus enabling long-term (> 10 years) T-cell production.

Consulter en ligne

Suggestions

Du même auteur

Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency.

Archive ouverte | Laffort, Caroline | CCSD

Haemopoietic stem-cell transplantation is a life-saving treatment for severe combined immune deficiency. However, there has been little long-term follow-up of this treatment. There is evidence for the persistance of partial immuno...

Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency

Archive ouverte | Neven, Bénédicte | CCSD

International audience. Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment for severe combined immunodeficiency (SCID). Detailed assessment of the long-term outcome of HSCT, ie, the oc...

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

Archive ouverte | Hacein-Bey-Abina, Salima | CCSD

International audience. Previously, several individuals with X-linked SCID (SCID-X1) were treated by gene therapy to restore the missing IL-2 receptor gamma (IL2RG) gene to CD34+ BM precursor cells using gammaretrov...

Chargement des enrichissements...